EQT‘s Galderma on Wednesday announced that its injectable drug nemolizumab helped patients suffering from the rare skin disease prurigo nodularis…
EQT‘s Galderma on Wednesday announced that its injectable drug nemolizumab helped patients suffering from the rare skin disease prurigo nodularis…